tiprankstipranks
Trending News
More News >
Champions Oncology Inc (CSBR)
NASDAQ:CSBR
US Market
Advertisement

Champions Oncology (CSBR) Ratios

Compare
140 Followers

Champions Oncology Ratios

CSBR's free cash flow for Q3 2025 was $0.61. For the 2025 fiscal year, CSBR's free cash flow was decreased by $ and operating cash flow was $0.26. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
0.99 0.90 1.13 1.13 1.12
Quick Ratio
0.99 0.90 1.13 1.13 1.12
Cash Ratio
0.16 0.47 0.52 0.42 0.69
Solvency Ratio
0.32 -0.07 0.11 0.10 -0.05
Operating Cash Flow Ratio
-0.07 0.18 0.37 -0.15 0.24
Short-Term Operating Cash Flow Coverage
0.00 3.27 6.16 0.00 0.00
Net Current Asset Value
$ -5.46M$ -10.22M$ -6.62M$ -7.53M$ -1.94M
Leverage Ratios
Debt-to-Assets Ratio
0.21 0.25 0.27 0.35 0.18
Debt-to-Equity Ratio
1.18 1.85 1.04 1.29 0.71
Debt-to-Capital Ratio
0.54 0.65 0.51 0.56 0.42
Long-Term Debt-to-Capital Ratio
0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
5.60 7.40 3.89 3.71 3.90
Debt Service Coverage Ratio
0.00 -1.77 2.04 0.00 0.00
Interest Coverage Ratio
0.00 0.00 25.29 0.00 0.00
Debt to Market Cap
0.00 0.02 0.01 0.00 0.00
Interest Debt Per Share
0.47 0.64 0.72 0.73 0.32
Net Debt to EBITDA
0.38 0.73 0.21 13.43 6.18
Profitability Margins
Gross Profit Margin
52.19%45.18%51.88%47.68%47.45%
EBIT Margin
10.87%-8.26%1.19%1.06%-4.94%
EBITDA Margin
14.42%-3.84%4.55%0.89%-2.29%
Operating Profit Margin
11.48%-8.26%1.24%0.82%-4.57%
Pretax Profit Margin
10.92%-9.78%1.19%1.00%-5.74%
Net Profit Margin
10.97%-9.90%1.12%0.88%-6.15%
Continuous Operations Profit Margin
10.97%-9.90%1.12%0.88%-6.52%
Net Income Per EBT
100.42%101.29%94.00%88.51%107.05%
EBT Per EBIT
95.18%118.39%96.05%121.01%125.68%
Return on Assets (ROA)
20.98%-15.55%1.55%1.31%-9.52%
Return on Equity (ROE)
656.65%-115.08%6.02%4.87%-37.14%
Return on Capital Employed (ROCE)
62.51%-35.37%3.39%2.06%-16.94%
Return on Invested Capital (ROIC)
62.77%-30.05%2.85%1.60%-16.91%
Return on Tangible Assets
21.22%-15.70%1.56%1.33%-9.67%
Earnings Yield
6.01%-8.11%0.54%0.26%-2.16%
Efficiency Ratios
Receivables Turnover
3.71 6.72 5.16 5.87 6.73
Payables Turnover
5.50 5.54 8.24 11.34 5.38
Inventory Turnover
0.00 29.53M 0.00 0.00 16.88M
Fixed Asset Turnover
5.63 3.71 3.20 2.81 4.73
Asset Turnover
1.91 1.57 1.39 1.49 1.55
Working Capital Turnover Ratio
-23.67 -1.18K 27.16 28.87 49.08
Cash Conversion Cycle
31.95 -11.65 26.41 29.94 -13.69
Days of Sales Outstanding
98.32 54.28 70.70 62.13 54.20
Days of Inventory Outstanding
0.00 <0.01 0.00 0.00 <0.01
Days of Payables Outstanding
66.36 65.93 44.30 32.19 67.89
Operating Cycle
98.32 54.28 70.70 62.13 54.20
Cash Flow Ratios
Operating Cash Flow Per Share
-0.09 0.29 0.49 -0.13 0.25
Free Cash Flow Per Share
-0.10 0.08 0.31 -0.38 0.06
CapEx Per Share
<0.01 0.21 0.18 0.25 0.19
Free Cash Flow to Operating Cash Flow
1.02 0.27 0.63 2.95 0.24
Dividend Paid and CapEx Coverage Ratio
-51.92 1.38 2.73 -0.51 1.31
Capital Expenditure Coverage Ratio
-51.92 1.38 2.73 -0.51 1.31
Operating Cash Flow Coverage Ratio
-0.20 0.46 0.69 -0.18 0.76
Operating Cash Flow to Sales Ratio
-0.02 0.07 0.13 -0.04 0.09
Free Cash Flow Yield
-1.23%1.65%4.06%-3.52%0.75%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.08 -12.34 184.95 389.45 -46.29
Price-to-Sales (P/S) Ratio
1.89 1.22 2.06 3.44 2.85
Price-to-Book (P/B) Ratio
20.07 14.20 11.14 18.98 17.19
Price-to-Free Cash Flow (P/FCF) Ratio
-83.71 60.77 24.64 -28.41 133.48
Price-to-Operating Cash Flow Ratio
-84.55 16.64 15.60 -83.87 31.47
Price-to-Earnings Growth (PEG) Ratio
0.02 0.01 3.67 -3.35 0.03
Price-to-Fair Value
20.07 14.20 11.14 18.98 17.19
Enterprise Value Multiple
13.50 -31.07 45.57 398.62 -118.21
Enterprise Value
111.08M 64.29M 101.81M 145.90M 86.89M
EV to EBITDA
13.15 -31.07 45.57 398.62 -118.21
EV to Sales
1.90 1.19 2.07 3.55 2.70
EV to Free Cash Flow
-83.96 59.37 24.75 -29.40 126.84
EV to Operating Cash Flow
-85.58 16.26 15.67 -86.79 29.91
Tangible Book Value Per Share
0.37 0.32 0.66 0.54 0.42
Shareholders’ Equity Per Share
0.40 0.34 0.69 0.57 0.45
Tax and Other Ratios
Effective Tax Rate
>-0.01 -0.01 0.06 0.18 -0.07
Revenue Per Share
4.28 3.98 3.72 3.12 2.71
Net Income Per Share
0.47 -0.39 0.04 0.03 -0.17
Tax Burden
1.00 1.01 0.94 0.89 1.07
Interest Burden
1.00 1.18 1.00 0.94 1.16
Research & Development to Revenue
0.12 0.21 0.19 0.18 0.18
SG&A to Revenue
0.16 0.19 0.19 0.16 0.21
Stock-Based Compensation to Revenue
0.01 0.02 0.02 0.01 0.02
Income Quality
-0.20 -0.74 11.86 -5.03 -1.47
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis